Literature DB >> 6094208

Interaction of the antihypertensive drug urapidil with cardiac beta-adrenoceptors in vitro.

M Freissmuth, E Tuisl, G Steurer, W Schütz.   

Abstract

A possible interaction of the antihypertensive drug, urapidil with beta-adrenoceptors was investigated in a guinea-pig ventricular membrane preparation. Urapidil at concentrations above 1 microM antagonized the isoproterenol-induced stimulation of adenylate cyclase activity. Urapidil 10 microM shifted the concentration-response curve for isoproterenol in a parallel manner to the right by a factor of 16. Urapidil competed with specific beta-adrenoceptor binding of [125I]iodocyanopindolol with an IC50 of 12 microM. Since the affinity of urapidil to beta-adrenoceptors appeared rather low, any beta-adrenoceptor blocking property may be of relevance in vivo at high dosages only.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094208     DOI: 10.1016/0014-2999(84)90385-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Platelet in vitro responses to urapidil and prazosin.

Authors:  C C Smith; D J Betteridge; B N Prichard
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  The effect of urapidil on responses to phenylephrine, angiotensin and isoprenaline in man.

Authors:  B Tomlinson; J C Renondin; B R Graham; B N Prichard
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Effect of urapidil on the performance of ischemic myocardium in anesthetized dogs.

Authors:  H Schad; W Heimisch; A Barankay; S Hesse; N Mendler
Journal:  Basic Res Cardiol       Date:  1990 May-Jun       Impact factor: 17.165

Review 4.  Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H D Langtry; G J Mammen; E M Sorkin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

5.  The assessment of the beta-blocking activity of urapidil: a new method.

Authors:  M J Jamieson; S H Jackson; S S Patel; A M Shepherd; H Galbraith; W Stewart; P H Flanagan
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.